JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedersen, K. E.
Right arrow Articles by Undem, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, K. E.
Right arrow Articles by Undem, B. J.

Vol. 292, Issue 1, 319-325, January 2000

Pharmacological Examination of the Neurokinin-1 Receptor Mediating Relaxation of Human Intralobar Pulmonary Artery1

Karen E. Pedersen, Carl K. Buckner, Sonya N. Meeker and Bradley J. Undem

Johns Hopkins School of Medicine (K.E.P., S.N.M., B.J.U.), Baltimore, Maryland; and University of Oklahoma College of Pharmacy (C.K.B.), Oklahoma City, Oklahoma

The effect of selective tachykinin receptor agonists and antagonists on human isolated intralobar pulmonary arterial rings was investigated. Neither Substance P (SP) nor neurokinin A (NKA) contracted the arteries. Both of these agonists, however, were potent and efficacious at relaxing the arteries that were precontracted with phenylephrine. The negative log (M) EC50 values for SP and NKA were 9.0 and 8.3, respectively. The neurokinin (NK)-3 selective agonist, senktide-analog, and the NK-2 receptor selective agonist, [beta -Ala8]NKA(4-10), caused neither contractions nor relaxations of the arteries, whereas the NK-1 receptor agonist Ac-[Arg6, Sar9, Met(O2)11]SP(6-11) (ASM-SP) relaxed the tissue with a potency similar to SP. The relaxations to SP, NKA, and ASM-SP were competitively antagonized by the selective NK-1 receptor antagonist CP 99994, with a pKb in the nanomolar range. Antagonism of the ASM-SP-induced relaxations was also noted with FK 888, RP 67580, and L 732,138, although these antagonists were much less potent than CP 99994 in this regard. Another NK-1 receptor selective antagonist, SR 140333, caused an insurmountable antagonism of the SP-induced relaxations. The NK-1 receptor-mediated relaxations could be blocked by removing the endothelium, or by a combination of N-nitro-L-arginine and indomethacin. Measurement of prostanoid generation revealed that in endothelial-intact but not endothelial-denuded tissue, ASM-SP caused a selective increase in the production of 6-keto-PGF1alpha , the stable metabolite of prostacyclin. The results indicate that stimulation of NK-1 receptors leads to relaxation of human intralobar pulmonary arteries, which is mediated largely by nitric oxide and prostacyclin released from the endothelium of these vessels.

1 This work was supported by the National Institutes of Health (Bethesda, MD) and by a generous gift from Zeneca Pharmaceuticals (Wilmington, DE).

0022-3565/0/2921-0319$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
A. Hegde, H. Zhang, S. M. Moochhala, and M. Bhatia
Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis
J. Leukoc. Biol., September 1, 2007; 82(3): 678 - 685.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. Lindstrom, B. von Mentzer, I. Pahlman, I. Ahlstedt, A. Uvebrant, E. Kristensson, R. Martinsson, A. Noven, J. de Verdier, and G. Vauquelin
Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1286 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Pal, M. J. Nemeth, D. Bodine, J. L. Miller, J. Svaren, S. L. Thein, P. J. Lowry, and E. H. Bresnick
Neurokinin-B Transcription in Erythroid Cells: DIRECT ACTIVATION BY THE HEMATOPOIETIC TRANSCRIPTION FACTOR GATA-1
J. Biol. Chem., July 23, 2004; 279(30): 31348 - 31356.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
B. Grubor, R. Ramirez-Romero, J. M. Gallup, T. B. Bailey, and M. R. Ackermann
Distribution of Substance P Receptor (Neurokinin-1 Receptor) in Normal Ovine Lung and During the Progression of Bronchopneumonia in Sheep
J. Histochem. Cytochem., January 1, 2004; 52(1): 123 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Springer and A. Fischer
Substance P-induced pulmonary vascular remodelling in precision cut lung slices
Eur. Respir. J., October 1, 2003; 22(4): 596 - 601.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
W. L. Rumsey, D. Aharony, R. A. Bialecki, B. M. Abbott, H. G. Barthlow, R. Caccese, S. Ghanekar, D. Lengel, M. McCarthy, B. Wenrich, et al.
Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 307 - 315.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.